Turn Therapeutics (NASDAQ:TTRX) Releases Earnings Results

Turn Therapeutics (NASDAQ:TTRX) issued its quarterly earnings data on Thursday. The company reported ($0.07) earnings per share (EPS) for the quarter, Zacks reports.

Turn Therapeutics Price Performance

Turn Therapeutics stock traded down $0.35 during trading hours on Thursday, hitting $4.05. 21,844 shares of the company traded hands, compared to its average volume of 945,030. Turn Therapeutics has a 1-year low of $3.65 and a 1-year high of $26.50.

Insider Transactions at Turn Therapeutics

In other news, insider Abraham Chesed purchased 14,286 shares of the firm’s stock in a transaction on Thursday, October 23rd. The stock was purchased at an average cost of $4.60 per share, with a total value of $65,715.60. Following the purchase, the insider owned 1,447,268 shares in the company, valued at $6,657,432.80. This trade represents a 1.00% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

About Turn Therapeutics

We are a pharmaceutical and medical device development company built around a proprietary platform technology designed to enhance drug performance. Our patented mixing process — commercially referred to as PermaFusion™ (“PermaFusion”) — enables stable suspension of polar, water-soluble active pharmaceutical ingredients (“APIs”) in oil-based carriers without the use of emulsifiers.